CAMP4 Therapeutics (CAMP) has an average rating of buy and mean price target of $8.36, according to analysts polled by FactSet.
What else is happening in Research?
Research
KeyBanc Downgrades Roku to Sector Weight From Overweight
Roku (ROKU) has an average rating of buy and mean price target of $151.96, according to analysts polled by FactSet.Price: $141.60, Change: $-2.06, Percent Change: -1.43%
$ROKU
Research
Jefferies Downgrades Roku to Hold From Buy, $160 Price Target
Roku (ROKU) has an average rating of buy and mean price target of $151.96, according to analysts polled by FactSet.Price: $142.12, Change: $-1.54, Percent Change: -1.07%
$ROKU
Research
Update: BofA Downgrades Runway to Underperform From Neutral, Cuts Price Target to $5.50 From $9
(Updated to include BofA's commentary)BofA Securities downgraded Runway Growth Finance (RWAY) to underperform from neutral, expecting profitability to continue to "disappoint."The current earnings deterioration in Q1, rising non-accruals, and lower NAV/share, amplified by the challenging operating backdrop for technology/software credit and large position sizes, analyst Derek Hewet wrote in a Monday note.Runway Growth Finance has an average rating of overweight and mean price target of $8.34, according to analysts polled by FactSet.Price: $5.83, Change: $-0.20, Percent Change: -3.30%
$RWAY